Firm News

Jury Awards 55 Million Dollars in Talcum Powder Suit

Publish Date : 05/09/2016

A jury in St. Louis ordered Johnson & Johnson to pay $55 Million to a woman who claims that use of their talcum powder caused her ovarian cancer. Gloria Ristesund, a 62 year old woman from Sioux Falls, South Dakota, is just one of more than 1,000 women who believe that the Johnson & Johnson product is responsible for their cancer. After decades of using Shower to Shower talcum powder as part of her daily hygiene regimen, Ristesund  developed ovarian cancer in 2011 and subsequently underwent a hysterectomy and the removal of he uterus, ovaries, and fallopian tubes. This is not the first jury verdict against Johnson & Johnson. In February the company lost a $72 Million verdict to the family of an Alabama woman who died of ovarian cancer last year.

Two major organizations, the American Cancer Society and the World Health Organization, both have expressed concern over the use of talcum powder for feminine hygiene. Several studies going back more than 30 years have also looked at talcum powder usage and the occurrence of  ovarian cancer. Many, including a 2008 study published in the Journal of Epidemiology and Community Health, have shown that women who use talcum powder are at a higher risk for cancer.

The lawyers at McSweeney/Langevin are closely examining the evidence tying the use of talcum powder to ovarian cancer. We are also investigating what Johnson & Johnson knew about the link and when they knew it. If you or a loved one have suffered from ovarian cancer after regularly using talcum powder, you may be able to make a claim against Johnson & Johnson. We would love to help you and your family get the compensation you deserve. Give us a call. 1-800-888-4425

 

Free Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing FREE

1-800-888-4425
FREE Case Review

An asterisk (*) indicates a required field.

[contact-form-7 id="96" title="Contact Us"]